Cross-neutralization tests were done on accepted species and recently isolated members of the genus Orthopoxvirus using antisera which had been separately absorbed with the various viruses. The results provided evidence for the involvement of four neutralizing antigens, and their distribution among 13 virus strains was determined. Monkeypox (Congo-8-Lombe), camelpox (Gorgan), ectromelia (Mill Hill), 'Lenny' and elephant poxviruses had distinctive antigenic formulae. Lister and Wyeth vaccines were indistinguishable but different from Copenhagen and EM63 vaccines which were themselves distinct. Cowpox (Brighton), buffalopox (BP4), MK10, and Moscow poxviruses were indistinguishable. Examples were found where viruses shared surface antigens but were not all ~eutralized by antibody to them. This reduced the practical value of the technique for virus identification. Evidence was also obtained for the existence in some viruses of a fifth antigen, antibody to which could block neutralization by antibody to one particular anti~n.
INTRODUCTION
Although Orthopoxvirus species are currently identified by biological methods other approaches are being tried. For example, some virus-specific differences have been found in the polypeptides of infected cells (Harper et al., 1979) and purified virions , and in the DNA fragments released by restriction endonucleases (Mfiller et al., 1978; Mackett & Archard, 1979) .
Serological methods have also been used. Downie (1939) showed that anti-vaccinia sera, absorbed with cowpox virus, still neutralized vaccinia virus. This was confirmed by Downie & McCarthy (1950) who also showed that smallpox was similar to vaccinia virus, and ectromelia similar to cowpox virus. They concluded that none of the viruses was immunologically identical, but did not pursue the matter further. McNeill (1968 b) concluded from the results of kinetic neutralization tests that vaccinia, cowpox, ectromelia and rabbitpox viruses were not identical but suggested that they shared a common neutralizing antigen. The LS antigen and the 'd' antigen of Rondle & Dumbell (1962) are located on the surface of vaccinia and cowpox viruses respectively, but antibody to them do not neutralize these viruses (Baxby, 1972) . More recently, an immunological comparison of vaccinia, cowpox and an orthopoxvirus isolated from captive elephants separated all three when absorbed antisera were used (Baxby & Ghaboosi, 1977) .
In this paper, cross-neutralization tests have been done on antisera absorbed with various orthopoxviruses. The results suggest that up to five surface antigens may be involved and a scheme is proposed to account for their distribution among 13 virus strains. 
METHODS
Virus strains. Accepted Orthopoxvirus species: vaccinia (Lister, Wyeth, EM63, Copenhagen vaccine strains), cowpox (Brighton strain), ectromelia (Mill Hill), camelpox (Gorgan), buffalopox (BP4), monkeypox .
Orthopoxviruses not yet assigned to species: 'Lenny' virus (Bourke & Dumbell, 1972) , 'elephant' virus (Baxby & Ghaboosi, 1977) , MK 10 (Shelukhina et al., 1975) , Russian carnivore virus (Marennikova et al., 1978) here designated 'Moscow' virus. Smallpox virus was not used.
Antisera. Antisera were prepared by scarifying the shaved flanks of rabbits with virus which had been similarly grown in the rabbit skin. The animals were re-infected 4 to 6 weeks later with high titre virus and serum obtained 10 days after that. Camelpox grows poorly if at all in the rabbit but sera were available from camels infected under controlled experimental conditions (Baxby et al., 1975) .
Serum absorption. Antisera from individual animals were absorbed with virus extracted from infected chorioallantoic membranes (CAM) and purified by Arcton treatment and differential centrifugation (Baxby, 1972) . A pellet of purified virus, the yield from 50 to 60 CAM, was resuspended in the antiserum (usually 5 ml of a 1/10 dilution) and incubated for 1 h at 37 °C and then overnight at +4 °C. The agglutinated virus was sedimented at 25000 g and the supernatant antiserum used to resuspend another pellet. When the antiserum had been completely absorbed, which usually took three pellets, it was centrifuged at 50000 g for 60 min and passed through a 200 nm membrane filter. After inactivation at 56 °C for 30 min the serum samples were stored at --70 °C.
Sometimes an antiserum which had been completely absorbed with one virus but which still neutralized others was then absorbed with a different virus, either to test a hypothesis (see e.g. Table 2 ) or to conserve antisera. An antiserum was considered to be completely absorbed when it had no neutralizing activity at the highest concentration tested (usually 1/30) against the absorbing virus and when further absorption did not reduce the titre of any residual antibody against another virus.
Neutralization tests. These were done by a standard method (Boulter, 1957) in which equal volumes of serum dilutions and constant virus were incubated at 37 °C for 2 h, at which time residual infectivity was detected by CAM inoculation. Virus suspensions used in neutralization tests were prepared from infected CAM by Arcton treatment and differential centrifugation. A single batch of each virus was used throughout. The titre of an antiserum was the dilution of the antiserum which permitted 50% virus survival in the test conditions, and was interpolated from the graph of % virus survival against log antiserum dilution.
Theoretical considerations
The results can perhaps be best understood by first considering the ways in which two hypothetical viruses A and B may react in neutralization tests with antibody to a hypothetical antigen X (Table 1) .
(i) Both viruses may have the antigen and be neutralized by antibody to it (Table t a ) . In this case the antigen can be designated X +, and so both A and B are X +.
(ii) Both viruses may have the antigen but only A is neutralized through it (Table I b) . A is X +, but in B the location and/or configuration of X is such that anti-X does not neutralize B. In this case the antigen in B may be designated X t+). The presence of X on virus B can be demonstrated by absorbing anti-X from an antiserum with virus B.
(iii) If virus A is X + and virus B did not have X, anti-X would neutralize A but not B, and virus B can be designated X-(Table 1 c). In this case virus B would not remove anti-X from an antiserum.
(iv) Virus A may be X C+) and virus B, X-( * X + = antigen present, virus neutralized by anti-X. X t+~ = antigen present, virus not neutralized by anti-X. X-= antigen absent, virus not neutralized by anti-X.
1" N, Neutralized; NN, not neutralized; (N), neutralized in absence of anti-Y; B, blocking antigen; NB, nonblocking antigen.
neutralized by anti-X, but the differences between the viruses could be demonstrated by testing their ability to absorb anti-X from an antiserum.
(v) Both viruses may be X ~+~ (Table 1 e ). The presence of the antigen can be demonstrated by absorption, but both viruses would give the same result.
(vi) The possibility of interference from other antigens should also be considered. In Table 1 (f) both viruses are X +. However, virus B has a second antigen Y so located that antibody to it will block neutralization of B by anti-X. Removal of anti-Y by absorption with an X-Y + virus would leave virus B open to neutralization by anti-X. In virus A antigen Y, if present, is so located that anti-Y does not block neutralization by anti-X. Antigen Y (and any other additional antigens) may exist in the Y+ or Yt+) state and this together with Y-, can be detected by schemes similar to the ones just outlined here for X. The existence of blocking antigens in poxviruses was deduced by McNeill (1968a) from the results of kinetic neutralization tests.
RESULTS
As the work progressed it was evident that absorption of each antiserum by each virus was unnecessary, and was wasteful of time and materials. Some viruses were shown to lack certain antigens and their antisera lacked antibody to them. Sera were selected for absorption on the basis of high neutralizing activity to a range of viruses, and from preliminary absorptions done with elephant and/or cowpox viruses. Only antisera to Lister vaccine (ALS), monkeypox (AMS), cowpox (ACS) and elephant (AES) viruses were absorbed with all the viruses. Other absorptions were done where necessary to detect possible virus-specific antigens, and to confirm the presence or absence of an antigen detected by using one of the above four antisera.
The limitation of this experimental approach is that there may be deficiencies in the antisera and that other antigens may exist which have not been detected here. ALS and ACS were typical of other antisera made against these viruses and used in previous absorption experiments (Baxby, 1972; Baxby & Ghaboosi, 1977) . Different antisera to elephant virus did not behave consistently. As explained below this led to the recognition of an antigen which had not been recognized previously. One antigen was poorly antigenic (see below) and none of three antisera made against monkeypox virus had antibody to it, although the antigen was present in monkeypox virus. The monkeypox antiserum used was of value in confirming the existence of the additional antigen mentioned above.
The results of cross-neutralization tests on ALS, AES, ACS and AMS before and after absorption with all the viruses are shown in Tables 3 to 6. The superscript numbers indicate the antigens through which the viruses are neutralized. Tables 3 to 6 can be interpreted with  reference to Table 2 . This outlines the various ways in which the antigens can be detected and is based in part on preliminary experiments with vaccinia, cowpox and elephant viruses, t IfX is 4 + then the cowpox antiserum should lack anti-4 (see text Antigen 4).
If X is 5-otherwise neutralization via 2 will be blocked. 9 If X is not 3 ÷ otherwise would be neutralized via this. II IfX is 4 5 .
IfX is 2-. IfX is not 2-Ep can be omitted. ** IfX is 2 + or 2 t+). ~'t If X is 2 +. $$ IfX is 2 4-. IfXis not 4-Cp can be omitted. 99 IfXisnot 2 .
reported previously but not analysed in detail (Baxby & Ghaboosi, 1977) . The present work suggested that five different antigens could be involved in neutralization of the various viruses.
Antigen 1 (antigen x of Baxby & Ghaboosi, 1977) As first demonstrated by Downie (1939) , anti-vaccinia sera absorbed with cowpox virus would still neutralize vaccinia virus but not cowpox. The two viruses crossqmmunize, so they share a common neutralizing antigen. This is here referred to as antigen 1. If vaccinia antisera absorbed with another orthopoxvirus do not neutralize cowpox, the unknown virus has antigen 1, and is probably 1+; because the viruses cross-immunize it is unlikely to be 1 ~+). If, after absorption with cowpox, the vaccinia antiserum still neutralizes the other orthopoxvirus, then vaccinia and this third virus, although sharing antigen 1 with cowpox, also share additional antigens lacking in cowpox as described below. Antigen 1 was detected in all the viruses and consequently appears to be the common neutralizing antigen postulated by McNeill (1968b) from the results of kinetic neutralization tests on vaccinia, cowpox, ectromelia and rabbitpox viruses. Table 3 . ~" AMS lacks anti-4 so these cross-neutralizations are < 1.4 (see Table 4 ). $ AMS has anti-5 which blocks neutralization through anti-2 (see Table 4 ). 
Cross-neutralization tests on anti-cowpox serum ( A CS) absorbed with various orthopoxviruses*

Antigens 2 and 5
As reported earlier (Baxby & Ghaboosi, 1977) , antisera to Lister vaccine and elephant viruses, absorbed with cowpox, would neutralize the homologous viruses (see also Table 3,  line 11; Table 4 , line 11). This indicated that Lister vaccine and elephant viruses had an antigen, then referred to as y which was not present in cowpox virus. This antigen is referred to here as antigen 2. Although further antisera to Lister vaccine behaved consistently as described above, some antisera to elephant virus did not. One such, AES2, is used in all Table  4 except line 11. In particular, this serum failed to neutralize elephant virus after absorption with the same strain of cowpox virus which had been used to absorb the other serum. This might simply suggest that AES2 lacks anti-2. However, this serum still neutralized Lister vaccine (Table 4 , line 12) and so should have anti-2. These results can be explained by suggesting that both AES 1 and AES2 have anti-2, but that AES2, used for all the absorptions in Table 4 (except line 11) and which fails to neutralize elephant virus after absorption with cowpox virus, has antibody to a 'blocking antigen' present in elephant virus but not in Lister vaccine or cowpox. It is suggested that reaction between this antigen and its antibody blocks neutralization of elephant virus through antigen 2, a situation postulated in Table 1 (f). This blocking antigen is referred to as antigen 5. Support for this explanation came from experiments in which AES2, postulated to contain anti-5 and incapable of neutralizing elephant virus, was absorbed with Lenny virus which was shown by other absorptions to be 2-. This serum so absorbed would then neutralize elephant virus (Table 4 , line 9), indicating the presense of anti-5 in AES2, and of antigen 5 on Lenny virus, and the removal of the blocking effect. Further support for this interpretation came from results of similar experiments with AMS (Table 5 , lines 9 and 11).
Antigen 3 (antigen z of Baxby & Ghaboosi, 1977) As described above, Lister vaccine and elephant virus have an antigen absent from cowpox. However, ALS absorbed with elephant virus would still neutralize Lister vaccine (Table 3 , line 6). This suggests that Lister vaccine has an antigen, here referred to as antigen 3, which is absent from both elephant and cowpox viruses.
Antigen 4 (antigen d of Baxby & Ghaboosi, 1977) ACS and AES, both absorbed with Lister vaccine, neutralized elephant but not cowpox virus (Table 4, line 2; Table 6 , line 2). Consequently, elephant virus is neutralized through an antigen, here referred to as antigen 4, which is not present on Lister vaccine. ACS has anti-4 although cowpox virus is not neutralized through it. That cowpox virus has antigen 4 was shown by absorbing anti-4 from ACS and AES with cowpox virus (Table 4, line 12; Table 6 , line 11). Evidently, elephant virus is 4 + and cowpox virus 4 t+~, a relationship postulated in Table 1 (b) . Antigen 4 is apparently poorly antigenic. Those antisera neutralizing through only anti-4 had low titres. Other antisera to 4 + or 4 ~+~ viruses had no detectable anti-4. This was unfortunately true of the monkeypox antiserum used ( Table 5 ). The possibility that the 'd' antigen of Rondle & Dumbell (1962) , which is also poorly antigenic, corresponds to the antigen here designated 4 has been discussed elsewhere (Baxby & Ghaboosi, 1977) . Antisera made against cowpox virus, but which lacked anti-4, were useful in detecting antigen 1; for all practical purposes they acted as monospecific anti-1 sera.
Distribution of the antigens
By using the schemes outlined in Table 2 , and the results of the absorptions listed in Tables 3 to 6, the suggested distribution of the five antigens among the 13 viruses is as shown in Table 7 . The way in which these data can be used to deduce an antigenic formula is shown in Orthopoxvirus surface antigens 259 apparently independent of all the others. Thus, among the various viruses each antigen occurred in the presence and absence of each other antigen. In general, the viruses could be placed into one of two categories. One contained viruses which were not neutralized by any absorbed antiserum. Thus, shared neutralizing antigen(s) had been absorbed, and the failure of the viruses to be neutralized by absorbed antisera was either due to the viruses lacking extra antigens, or having them in the X ~+) state. The cross-neutralization among these viruses, and between these viruses and those in the second category, was due to antigen 1 + which could be absorbed from an antiserum to any virus by any virus. In this first category were cowpox, buffalopox, Moscow and MK10 viruses which were shown to be 4 ~+), ectromelia which was shown to be 2 ~+), 5 ~+), and Lenny virus (Table 8) which was shown to be 3 ~+), 4 ~+),
5(+~.
The second category contained viruses which were neutralized by some of the absorbed antisera. In addition to having antigen 1 + which linked them to each other and to the viruses discussed immediately above, they each shared neutralizing antigens with the antibodyinducing virus which were missing from the absorbing virus. The simplest virus in this category was camelpox virus which had just 4 + in addition to antigen 1 ÷. Elephant and monkeypox viruses shared 2, 4 + and 5 (+), but differed in that the former was 2 + and the latter was 2 ~+~. The four vaccine strains were not identical and were separated from all other viruses except Lenny virus by having antigen 3, and from all except elephant virus by being 2 +. The vaccine strains were the only viruses to have both antigens 2 and 3. The Lister and Wyeth vaccines were indistinguishable and were conspicuous in being 3 +. Copenhagen and EM63 vaccines differed from the other two in being 3 t+), 5~÷); in addition, Copenhagen was 4 (+). Copenhagen vaccine was the only virus which had all five antigens; Anderson & Skegg (1970) concluded from tests on unabsorbed antisera that it differed from Lister and Wyeth vaccines.
DISCUSSION
The generally held view that orthopoxviruses are closely-related immunologically is supported by the results obtained here. No evidence was obtained of antigens specific for particular viruses; the differences were found in the distribution of antigens 2 to 5 among the different viruses. However, this experimental approach is limited by the antibody spectrum of the antisera used; there may be other neutralizing antigens, even virus-specific ones, which may be detected by more potent antisera. Consequently, the distribution of antigens shown in Table 7 should perhaps be regarded as a provisional scheme which can be tested by the use of monoclonal antibodies produced by hybridomas.
Some viruses have additional antigens which have not been detected here. For example, the LS antigen is present on the surface of Lister vaccine but not cowpox, but as antisera to LS do not neutralize vaccinia (Baxby, 1972) , the methods described here would not detect it. Failure to detect the monkeypox-specific Mo antigen was a disappointment. This antigen has been detected by immuno-diffusion (Gispen & Brand-Saathof, 1974) and if it is also located on the virion, it evidently plays no part in neutralization.
The hope that the results would enable individual viruses to be recognized was not entirely realized. For example, cowpox, buffalopox, MK10, and Moscow viruses, which can be separated on biological criteria (Baxby, 1975; Baxby et al., 1979) , apparently have the same antigens. Three of the four vaccine strains have different antigens and it is possible that other vaccine strains, and smallpox virus which could not be examined here, may have the same antigens as viruses shown here to be unique. In addition, only single strains of cowpox, ectromelia, monkeypox and camelpox were examined and it is possible that strain differences exist here. Subject to these reservations, two vaccines, camelpox, monkeypox, ectromelia, Lenny and elephant viruses have distinct antigenic formulae. However, practical problems were caused by antigens which existed in the X (+~ form and which could be detected only by absorption even if monospecific antisera were available. Attempts to neutralize viruses through X (+) antigens by the addition of complement to the system were unsuccessful (D. Baxby, unpublished results).
Nevertheless, the results obtained are of some potential practical value. The natural reservoirs of cowpox and elephant viruses are believed to be small wild mammals, not yet recognized (Baxby, 1977) , and information on the reservoirs could be obtained by serological surveys of wild animals. For example, detection of anti-2 in European animals would exclude cowpox and Moscow virus and indicate infection with elephant or ectromelia virus whereas detection of anti-4 would exclude the latter.
